Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.39 |
| ▸ | GCLC | P48506 | 2/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15995454 | 0.89 | CA2 (0.57) | CA2MAPK1CHRM1ADRA1AAKR1A1 | |
| SCHEMBL27714784 | 0.82 | SLC1A1 (0.38) | CHRM1ADRA1AAKR1A1CHRM3HTR2A | |
| SCHEMBL27721756 | 0.82 | CA2 (0.42) | CA2MAPK1CHRM1ADRA1AAKR1A1 | |
| SCHEMBL27701090 | 0.82 | CA2 (0.42) | CA2MAPK1CHRM1ADRA1AAKR1A1 | |
| SCHEMBL31519378 | 0.76 | SLC1A2 (0.55) | SLC1A2SLC1A1SLC1A3GRIK1GRIK2 | |
| SCHEMBL27809324 | 0.75 | GABRR1 (0.46) | CYP1A2 | |
| SCHEMBL125406 | 0.75 | CA2 (0.71) | CA2MAPK1CHRM1ADRA1AAKR1A1 | |
| SCHEMBL3125777 | 0.74 | CA2 (0.48) | CA2MAPK1CHRM1ADRA1AAKR1A1 | |
| SCHEMBL17311980 | 0.72 | TET2 (0.44) | — | |
| SCHEMBL13873420 | 0.72 | TET2 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250135016-A1 | MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION | UNIVERSITY OF WASHINGTON (US) | 2025-05-01 | — | — | US | disclosed |
| US-20200188524-A1 | MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION | UNIVERSITY OF WASHINGTON | 2020-06-18 | — | — | US | disclosed |
| WO-2018057941-A1 | MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION | UNIVERSITY OF WASHINGTON (US) | 2018-03-29 | — | — | WO | disclosed |
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2017-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250135016-A1 | MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION | LIG4, LIG1, PCNA | CA2 1048/4885MAPK1 4342/4885CHRM1 3758/4885 |
| US-20200188524-A1 | MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION | LIG4, LIG1, PCNA | CA2 1048/4885MAPK1 4342/4885CHRM1 3758/4885 |
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | ENY2, ENO1, IDH1 | CA2 614/4885MAPK1 3587/4885CHRM1 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.